PURE Bioscience (PURE) Short Interest Ratio & Short Volume → Automatic Income (from home) (From Awesomely, LLC) (Ad) Free PURE Stock Alerts $0.07 -0.01 (-12.50%) (As of 05/3/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest PURE Bioscience Short Interest DataCurrent Short Volume2,700 sharesPrevious Short Volume400 sharesChange Vs. Previous Month+575.00%Dollar Volume Sold Short$206.82Short Interest Ratio / Days to Cover0.0Last Record DateApril 15, 2024Outstanding Shares111,860,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume1,450 sharesAverage Trading Volume22,675 sharesToday's Volume Vs. Average6% Short Selling PURE Bioscience ? Sign up to receive the latest short interest report for PURE Bioscience and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPURE Short Interest Over TimePURE Days to Cover Over TimePURE Percentage of Float Shorted Over Time Ad Paradigm PressNever use this word on your phone (FBI could be watching)This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...Watch my unredacted video about what I think is coming next right here PURE Bioscience Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20242,700 shares $206.82 +575.0%N/A0 $0.08 3/31/2024400 shares $39.60 No ChangeN/A0 $0.10 3/15/2024400 shares $36.00 -97.7%N/A0 $0.09 2/29/202417,200 shares $1,886.84 -37.9%N/A1 $0.11 2/15/202427,700 shares $2,963.90 +3,362.5%N/A0.3 $0.11 1/15/20241,700 shares $213.01 +325.0%N/A0 $0.13 Get the Latest News and Ratings for PURE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PURE Bioscience and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023400 shares $51.86 -97.2%N/A0 $0.13 12/15/202314,300 shares $2,145.00 +2,760.0%N/A0.1 $0.15 11/30/2023500 shares $59.00 -44.4%N/A0 $0.12 11/15/2023900 shares $92.97 +125.0%N/A0 $0.10 10/31/2023400 shares $32.40 No ChangeN/A0 $0.08 10/15/2023400 shares $47.20 -94.0%N/A0 $0.12 9/30/20236,700 shares $743.70 -10.7%N/A0.1 $0.11 9/15/20237,500 shares $757.50 -61.9%N/A0.1 $0.10 8/31/202319,700 shares $2,068.50 -36.9%N/A0.4 $0.11 8/15/202331,200 shares $3,744.00 +766.7%N/A0.6 $0.12 7/31/20233,600 shares $306.00 -25.0%N/A0.4 $0.09 7/15/20234,800 shares $528.00 +500.0%N/A0.1 $0.11 6/30/2023800 shares $63.92 +100.0%N/A0 $0.08 6/15/2023400 shares $35.85 No ChangeN/A0 $0.09 5/31/2023400 shares $44.40 -93.1%N/A0 $0.11 5/15/20235,800 shares $640.90 -55.0%N/A0.2 $0.11 4/30/202312,900 shares $1,161.00 +101.6%N/A0.1 $0.09 4/15/20236,400 shares $640.00 -14.7%N/A0 $0.10 3/31/20237,500 shares $1,148.06 +368.8%N/A0.1 $0.15 3/15/20231,600 shares $228.32 -90.0%N/A0 $0.14 2/28/202316,000 shares $2,160.00 +3,900.0%N/A0.3 $0.14 2/15/2023400 shares $56.00 -96.2%N/A0 $0.14 1/31/202310,600 shares $1,375.88 +715.4%N/A0.3 $0.13 1/15/20231,300 shares $130.00 +225.0%N/A0 $0.10 12/30/2022400 shares $33.92 -93.8%N/A0 $0.08 12/15/20226,400 shares $851.84 -65.6%N/A0.1 $0.13 11/30/202218,600 shares $2,788.14 +463.6%N/A0.1 $0.15 11/15/20223,300 shares $561.50 -88.5%N/A0.1 $0.17 10/31/202228,600 shares $4,807.66 +5.9%N/A0.3 $0.17 10/15/202227,000 shares $5,211.00 +23.9%N/A1.9 $0.19 9/30/202221,800 shares $4,360.00 +1.4%N/A0.2 $0.20 9/15/202221,500 shares $4,942.85 -40.9%N/A0 $0.23 8/31/202236,400 shares $7,280.00 +23.0%N/A0.2 $0.20 8/15/202229,600 shares $6,808.00 -1.3%N/A0.2 $0.23FW: 234x Gain (Ad)This coin is an essential building block for an ongoing financial revolution of massive dimensions. As a big part of this revolution, the big banks of the world must connect to the blockchain.Click here. PURE Short Interest - Frequently Asked Questions What is PURE Bioscience's current short interest? Short interest is the volume of PURE Bioscience shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 2,700 shares of PURE short. Learn More on PURE Bioscience's current short interest. Is PURE Bioscience's short interest increasing or decreasing? PURE Bioscience saw a increase in short interest in April. As of April 15th, there was short interest totaling 2,700 shares, an increase of 575.0% from the previous total of 400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does PURE Bioscience's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to PURE Bioscience: Cosmos Health Inc. (2.93%), NeuroMetrix, Inc. (0.08%), Precipio, Inc. (0.41%), PreveCeutical Medical Inc. (0.00%), Genetic Technologies Limited (0.41%), CB Scientific, Inc. (0.00%), Pressure BioSciences, Inc. (0.01%), Pacific Health Care Organization, Inc. (0.00%), BetterLife Pharma Inc. (0.01%), Aeterna Zentaris Inc. (0.35%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short PURE Bioscience stock? Short selling PURE is an investing strategy that aims to generate trading profit from PURE Bioscience as its price is falling. PURE shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against PURE Bioscience? A short squeeze for PURE Bioscience occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PURE, which in turn drives the price of the stock up even further. How often is PURE Bioscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PURE, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: COSM Short Squeeze NURO Short Squeeze PRPO Short Squeeze PRVCF Short Squeeze GENE Short Squeeze CBSC Short Squeeze PBIO Short Squeeze PFHO Short Squeeze BETRF Short Squeeze AEZS Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:PURE) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024AltimetryBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe only AI company you should be looking atBehind the Markets